5-HTP for Sleep Onset Difficulty
D Early Research Only preliminary research exists (lab studies, case reports).Based on 7 studies. 7/7 studies show positive effects.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Dsleep\u002Donset\u002Dlatency';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
D
The Bottom Line
There is not yet enough human research to confirm that 5-HTP helps you fall asleep faster, though early animal research is encouraging.
- All 7 studies are animal or preclinical studies with no human trial data
- Evidence grade is D, indicating very limited evidence
- 5-HTP works through the serotonin system, which plays a role in sleep onset
- Human clinical trials are needed before recommendations can be made
Key Study Findings
Animal study
Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 …
Dose: None
vs: Placebo
Effect: None
None
Animal Study
Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats.
Dose: Cinnamic acid (CA) administered to rats (dose not specified)
vs: Placebo
Effect: None
None
animal study (preclinical)
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides.
Dose: up to 96 mg/kg
vs: Placebo
Effect: None
None
animal study (preclinical)
Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems.
Dose: not fully specified (dose ranges tested in Drosophila, ICR mice, and SD rats)
vs: Placebo
Effect: None
p < 0.001 (combined GABA/5-HTP
animal study (preclinical)
Flos Albiziae aqueous extract and its active constituent quercetin potentiate the hypnotic effect of pentobarbital …
Dose: various doses; pentobarbital 50 mg/kg (full dose) or 28 mg/kg (sub-hypnotic dose) IP
vs: Placebo
Effect: None
None
In Vitro
Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep …
Dose: 5-45 mg/kg i.p. schizandrin
vs: Placebo
Effect: Dose-dependent decrease in sleep latency and increase in sleep duration
None
Key Statistics
7
Studies
--
Participants
↑
Positive
D
Grade
Referenced Papers
Psychopharmacology
2025
5 citations
International immunopharmacology
2025
1 citations
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides.
Other
RSC advances
2019
13 citations
Nutrition research and …
2018
12 citations
Biomedical reports
2015
12 citations
European journal of …
2014
43 citations
Pharmacology, biochemistry, and …
2008
76 citations
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- sleep:
- 100-300 mg, 30-45 min before bed
Upper limit: Not established; serotonin syndrome risk with SSRIs
Dosages Studied in Research
| Dosage | Duration | Effect | N |
|---|---|---|---|
| None | -- | Positive | -- |
| Cinnamic acid (CA) administered to rats (dose not specified) | -- | Positive | -- |
| up to 96 mg/kg | -- | Positive | -- |
| not fully specified (dose ranges tested in Drosophila, ICR mice, and SD rats) | -- | Positive | -- |
| various doses; pentobarbital 50 mg/kg (full dose) or 28 mg/kg (sub-hypnotic dose) IP | -- | Positive | -- |
| 5-45 mg/kg i.p. schizandrin | -- | Positive | -- |
| Spinosin various doses; pentobarbital 45 mg/kg or 28 mg/kg i.p.; 5-HTP 2.5 mg/kg i.p.; PCPA 300 mg/k | -- | Positive | -- |
Best taken: 30-45 minutes before bed
Safety & Side Effects
Reported Side Effects
- ⚠ Nausea
- ⚠ Diarrhea
- ⚠ Heartburn
- ⚠ Stomach pain
- ⚠ Drowsiness
Known Interactions
- ● SSRIs/SNRIs — serious risk of serotonin syndrome
- ● MAOIs — dangerous serotonin accumulation
- ● Tramadol — increased serotonin syndrome risk
- ● Carbidopa — may cause scleroderma-like skin changes
Tolerable upper intake: Not established; serotonin syndrome risk with SSRIs
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does 5-HTP help with Sleep Onset Difficulty?
Based on 7 studies with 0 participants, there is preliminary evidence that needs more research that 5-HTP may support Sleep Onset Difficulty management. Our evidence grade is D (Very Early Research).
How much 5-HTP should I take for Sleep Onset Difficulty?
Studies have used various dosages. A commonly studied range is 100-300 mg, 30-45 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Diarrhea, Heartburn, Stomach pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and Sleep Onset Difficulty?
We rate the evidence as Grade D (Very Early Research). This rating is based on 7 peer-reviewed studies with 0 total participants. The overall direction of effect is positive.
Related Evidence
Other ingredients for Sleep Onset Difficulty
5-HTP for other conditions
References
- [1] Jingyi Li et al.. Psychopharmacology (Berl). 2025. Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. doi:10.1007/s00213-025-06828-5 PubMed
- [2] Xiaona Ye et al.. Int Immunopharmacol. 2025. Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats. doi:10.1016/j.intimp.2025.114852 PubMed
- [3] Ning Mou et al.. RSC Adv. 2019. Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides. doi:10.1039/c9ra01549c PubMed
- [4] Ki-Bae Hong et al.. Nutr Res Pract. 2018. Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems. doi:10.4162/nrp.2018.12.3.208 PubMed
- [5] Meng-Fei Ye et al.. Biomed Rep. 2015. Flos Albiziae aqueous extract and its active constituent quercetin potentiate the hypnotic effect of pentobarbital via the serotonergic system. doi:10.3892/br.2015.518 PubMed
- [6] Chenning Zhang et al.. Eur J Pharmacol. 2014. Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep behaviors in mice. doi:10.1016/j.ejphar.2014.09.012 PubMed
- [7] Li-En Wang et al.. Pharmacol Biochem Behav. 2008. Spinosin, a C-glycoside flavonoid from semen Zizhiphi Spinozae, potentiated pentobarbital-induced sleep via the serotonergic system. doi:10.1016/j.pbb.2008.03.022 PubMed
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.